Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2003
10/09/2003WO2003082826A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003WO2003082593A1 Optical recording media and dipyrromethene-metal chelate compounds
10/09/2003WO2003082298A1 Statin therapy for enhancing cognitive maintenance
10/09/2003WO2003082294A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases
10/09/2003WO2003082288A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191174 Novel bicyclic compounds
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191128 Anticancer agents; antiproliferative agent
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191027 Herbicides
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2479928A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003CA2479819A1 Process for the preparation of morpholine derivatives and intermediates therefore
10/08/2003EP1350791A1 Process for converting dihydroisoxazole derivatives to gamma-hydroxyamino acid derivatives, e.g. monatins
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349837A1 Antitumoral carbazoles
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349535A2 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products
10/08/2003EP1001935B1 Indole derivatives as mcp-1 receptor antagonists
10/08/2003EP0882707B1 Novel tricyclic compounds and drug compositions containing the same
10/08/2003CN1447806A 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors
10/08/2003CN1447684A Stable gabapentin having PH within controlled range
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630496 Inhibitors of phospholipase enzymes
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630004 Ready-to-use dyeing composition for keratinous fibers comprising, in dyeing medium, oxidizing agent chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts and enzymes, and specified oxidation base
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2247300C (3-oxoisoindolin-1-ylidine) propandinitrile derivatives and method for preparing the same
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003WO2003080597A1 Method for manufacture of sertindole
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080049A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003WO2003080048A1 (-)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003US20030187054 Preparations for chondrogenesis
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187012 Reduction physical cigarette smoking
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186944 Novel aromatic compounds
10/02/2003US20030186901 Method of inhibiting neurotrophin-receptor binding
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186448 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis
10/02/2003US20030186077 Bis- and tris- (di) benzocarbazole-based materials as hole transport materials for organic light emitting devices
10/02/2003US20030185756 Carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues
10/02/2003CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003CA2477771A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1348684A1 Method for synthesis of (2S)-indoline-2-carboxylic acid; and use in the synthesis of perindopril
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP1071665B1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0882711B1 Indole derivatives and rooting inducers comprising the same as the active ingredient
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1445211A New amide ramification of sweetsop as well as its preparing method, its medication composition and usage
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627650 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents.
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003WO2003078394A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003US20030181733 Method for producing indols
09/25/2003US20030181732 Process for the preparation of optically active 7-substituted 3-(2-aminopropyl)indole derivatives and intermediates therefor
09/25/2003US20030181731 Process for producing 5-fluorooxyindole and for producing intermediates therefor